CAS No. |
23141-25-5 |
中文名称 |
(1R,2S,13bS,14aS)-2-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-1-乙烯基-1,2,7,8,13,13b,14,14a-八氢-5H-吲哚并[2,3-a]吡喃并[3,4-g]喹诺里嗪-5-酮 |
英文名称 |
(1R,2S,13bS,14aS)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1-vinyl-1,2,7,8,13,13b,14,14a-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one |
别名 |
(15β)-19,20-Didehydro-16α-ethenyl-17β-(β-D-glucopyranosyloxy)-18-oxayohimban-21-one;(1R)-1β-Ethenyl-2α-(β-D-glucopyranosyloxy)-1,2,7,8,13,13bβ,14,14aα-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one;1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one;Strictosamide;5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one,1-ethenyl-2-(b-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-,(1R,2S,13bS,14aS)-;5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one, 1-ethenyl-2-(β-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-, (1R,2S,13bS,14aS)-;strictosidinelactam;pain,antifungal,Anti-inflammatory,Parasite,inhibit,Inhibitor,antiplasmodial,Fungal,Strictosamide |
标准英文名 |
(1R,2S,13bS,14aS)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1-vinyl-1,2,7,8,13,13b,14,14a-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one |
MDL No. |
MFCD14105616 |
分子式 |
C26H30N2O8 |
分子量 |
498.53
|
精确分子量 |
498.20
|
SMILES |
C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C2C(=O)N3CCC4=C(NC5=CC=CC=C45)[C@@H]3C[C@H]21 |
标准SMILES |
C=C[C@H]1[C@@H](OC=C2[C@H]1C[C@H]1C3NC4=CC=CC=C4C=3CCN1C2=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |
用途 |
Anti-inflammatory; analgesic (for inflammatory pain); antiplasmodial; antifungal |
InChIKey |
LBRPLJCNRZUXLS-IUNANRIWSA-N |